News

Loteprednol etabonate ophthalmic gel, 0.38%, is a corticosteroid indicated for the treatment of postoperative inflammation ...
Asian Paints sells stake in Akzo Nobel India, GAIL extends gas agreement, SEBI proposes new guidelines, companies announce ...
Global Pharma major Lupin Limited and Zentiva Group, a pan-European pharmaceutical company, have entered into a license and ...
Vaibhav Vidwani, fundamental research analyst at Bonanza Portfolio Ltd., and Sarvendra Srivastava, market strategist at 5 ...
Lupin Ltd has entered into a License and Supply Agreement with Zentiva, k.s., for commercialization of Lupin's biosimilar Certolizumab Pegol.
Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...
Lupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The ...
Pharma major Lupin Ltd on Wednesday said it has inked a license and supply pact for commercialisation of its biosimilar 'Certolizumab Pegol' across multiple global markets with the Zentiva Group, ...
Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...
It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...
Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...